Viking Therapeutics Trades Well Below Its Wall Street Targets. Here’s the Skeptics’ Case.
Investors always need to appreciate risk before buying into any clinical-stage biopharmaceutical company.
Cerebras Has a $25.4 Billion Backlog, and One OpenAI Agreement Is Behind Much of It
The AI computing specialist’s latest results were strong. The real story is a backlog worth almost 29 times this year’s expected revenue.
IonQ vs. Rigetti Computing: Which Pure-Play Quantum Pioneer Has the Stronger Technology Advantage?
Rigetti and IonQ are taking two separate approaches to quantum computing.
This “new” frog was hiding in plain sight for 100 years
A common frog found across Ecuador and Colombia has finally been recognized as its own species after more than a century of mistaken identity. Museum specimens from the 1800s helped scientists reveal that Pristimantis milpe had been hiding in plain sig…
Why Intel Stock Climbed This Week
Dell’s torrid revenue growth bodes well for the semiconductor leader.
Some joints may be primed for rheumatoid arthritis before birth
Scientists have found evidence that vulnerability to rheumatoid arthritis may begin before birth. Finger joints commonly affected by the disease develop with different tissue structures and larger populations of specialized fibroblasts than joints that…
Donald Trump’s Tariff Policy Has Repeatedly Triggered Multi-Trillion-Dollar Stock Swings Since Early 2025. Here’s Why Markets Still Struggle to Price In His Next Move.
The president’s unique approach to trade policy is creating a lot of volatility.
Prediction: Here’s What a $10,000 Investment in Rocket Lab Will Be Worth in 5 Years
It’s hard to make predictions, especially about the future.
AMD Committed Up to $5 Billion to Anthropic, and Anthropic’s IPO Prospectus Is Reportedly Days Away
The chipmaker’s up-to-$5 billion pledge comes with conditions attached — and the company on the receiving end is about to get a public price.
QuantumScape Stock Is Worth a Closer Look Right Now
This solid-state battery maker’s technology provides benefits to both the electric vehicle and artificial intelligence sectors.
Coca-Cola Stock at $88: Here’s Why Investors Should Pause
The stock of Coca-Cola’s archrival and the behavior of a prominent shareholder strongly indicate it is a hold.
Compound in blueberries may help muscle cells burn excess fat
Scientists in Japan have identified a natural compound found in blueberries, grapes, and other berries that may help muscle cells burn excess fat instead of storing it. The compound, pterostilbene, reduced abnormal fat buildup in cultured mouse muscle …
Think You’ll Claim Social Security at 62? Ask Yourself These 3 Questions First.
There are different factors to consider before putting in an early claim.
If You Buy Amazon With $10,000 at a 10% Discount From Its High, Here’s What I Predict It Could Be Worth in 10 Years
This “Magnificent Seven” stock likely won’t have the same 561% return that it posted in the past decade.
Chevron’s Iraq Bet Isn’t the Real Dividend Growth Story. Here’s What Is.
Chevron is looking to produce more energy from Iraq and make it easier to bring to market, but that’s just normal business.
Are Stocks Going to Plunge if Congress Is Split Under President Donald Trump? Here’s What History Says About Stock Market Returns in This Scenario.
Nearly a century of historical return data shows what happens when the political puzzle pieces are rearranged on Capitol Hill.
My Top Nuclear Stock to Buy Right Now (and It’s Not Even Close)
Nuclear stocks are benefiting from increased AI spending.
Why UiPath Rallied in August
Although the stock has pulled back after its early September earnings report.
History Says That Bitcoin Is an Unbelievable Bargain Right Now
Multiple signals suggest that Bitcoin’s price is unusually low.
Enterprise Products Partners: Buy, Sell, or Hold?
Enterprise Products Partners offers an attractive yield, a strong distribution history, and, best of all, energy exposure without the commodity risk.